This is a great article and I agree that novel diagnostic tools, criteria, and norms are necessary. I’d say though that biomarkers such as Amyloid measurements from either the brain using PET imaging, or from cerebrospinal fluid (as well as other different biomarkers) can help to differentiate normal from abnormal cognitive aging, even in highly educated individuals.